DDW Editor Reece Armstrong looks at the challenges and opportunities for biobanking in drug discovery. The biobanking market was worth $81.29 billion in 2024 according to GrandView Research1 and is expected to reach $126.7 billion by 2030. A legacy sector for life sciences, biobanks have acted as repositories for research… Read More
A world-first ‘epigenetic map’ of the human genome could lead to breakthroughs in new diagnoses and treatments, say UK scientists. This new resource for medical researchers will be created though a new strategic partnership between the UK government, Oxford Nanopore Technologies, UK Biobank, NHS England and Genomics… Read More
Work has started on a £60 ($75.1) million development in Manchester intended to enhance the city’s Oxford Road Corridor knowledge quarter as a hub for life sciences and technology innovation. Greenheys at Manchester Science Park is scheduled for completion in Summer 2026 and will span 131,000… Read More
